Nano Terra, a Brighton, MA-based company that works with industry on surface engineering and nanotechnology projects, said today that it has acquired the drug developer Surface Logix. The terms and details of the deal were not disclosed. Harvard University chemist George Whitesides (an Xconomist) is a founder of both Nano Terra and Surface Logix. “Surface Logix is an excellent fit for Nano Terra since our business was also built on intellectual property from the Whitesides lab,” said Myer Berlow, CEO of Nano Terra, in a statement. “We think we can achieve significant synergies through our proven co-development model. This acquisition opens the door to the use of Nano Terra’s technology in a variety of healthcare products.”
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
